$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

$esta Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000168875724000034 Filed on March 04, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$37.17M	$31.56M	$165.2M
YoY Change	-20.11%	-27.97%	2.13%
Cost Of Revenue	$12.79M	$10.98M	$58.17M
YoY Change	-22.24%	-29.86%	5.57%
Gross Profit	$24.38M	$20.59M	$107.0M
YoY Change	-18.95%	-26.91%	0.36%
Gross Profit Margin	65.6%	65.22%	64.78%
Selling, General & Admin	$28.94M	$36.88M	$145.6M
YoY Change	-8.72%	5.84%	15.55%
% of Gross Profit	118.71%	179.16%	136.08%
Research & Development	$4.273M	$5.820M	$26.43M
YoY Change	-34.59%	-10.17%	30.39%
% of Gross Profit	17.53%	28.27%	24.7%
Depreciation & Amortization	$900.0K	$1.222M	$2.800M
YoY Change	-3.85%	23.56%	-27.65%
% of Gross Profit	3.69%	5.94%	2.62%
Operating Expenses	$33.21M	$42.70M	$172.0M
YoY Change	-13.14%	3.33%	17.61%
Operating Profit	-$8.834M	-$22.11M	-$65.03M
YoY Change	8.26%	68.05%	63.97%
Interest Expense	$4.381M	-$634.0K	$15.39M
YoY Change	16.64%	-249.18%	30.89%
% of Operating Profit
Other Income/Expense, Net	-$3.037M	-$298.0K	$816.0K
YoY Change	-516.6%	3625.0%	-125.68%
Pretax Income	-$15.76M	-$23.05M	-$78.58M
YoY Change	41.86%	80.86%	7.91%
Income Tax	$438.0K	-$2.505M	-$81.00K
% Of Pretax Income
Net Earnings	-$16.20M	-$20.54M	-$78.50M
YoY Change	35.67%	51.47%	4.38%
Net Earnings / Revenue	-43.59%	-65.09%	-47.53%
Basic Earnings Per Share	-$0.58		-$3.07
Diluted Earnings Per Share	-$0.58	-$0.79	-$3.07
COMMON SHARES
Basic Shares Outstanding	27.21M shares	25.81M shares	25.60M shares
Diluted Shares Outstanding	27.79M shares		25.60M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$72.98M	$40.04M	$40.04M
YoY Change	70.33%	-39.67%	-39.67%
Cash & Equivalents	$72.98M	$40.04M
Short-Term Investments
Other Short-Term Assets	$6.596M	$7.404M	$7.404M
YoY Change	60.17%	178.56%	-27.0%
Inventory	$72.49M	$79.47M	$79.47M
Prepaid Expenses
Receivables	$50.84M	$46.92M	$46.92M
Other Receivables	$792.0K	$1.073M	$1.073M
Total Short-Term Assets	$203.7M	$174.9M	$174.9M
YoY Change	43.41%	16.68%	16.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$79.24M	$77.21M	$80.59M
YoY Change	38.9%	51.11%	47.07%
Goodwill	$465.0K	$465.0K
YoY Change	0.0%	0.0%
Intangibles	$9.515M	$7.987M
YoY Change	117.88%	73.33%
Long-Term Investments
YoY Change
Other Assets	$5.011M	$4.702M	$4.702M
YoY Change	248.71%	264.5%	264.5%
Total Long-Term Assets	$98.14M	$93.74M	$93.74M
YoY Change	45.79%	53.28%	53.28%
TOTAL ASSETS
Total Short-Term Assets	$203.7M	$174.9M	$174.9M
Total Long-Term Assets	$98.14M	$93.74M	$93.74M
Total Assets	$301.8M	$268.6M	$268.6M
YoY Change	44.17%	27.28%	27.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$31.07M	$41.62M	$41.62M
YoY Change	53.4%	107.77%	107.77%
Accrued Expenses	$15.21M	$13.69M	$13.58M
YoY Change	-22.56%	-20.58%	-21.21%
Deferred Revenue	$1.739M	$1.836M
YoY Change	10.13%	8.77%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$48.02M	$57.15M	$57.15M
YoY Change	15.78%	46.69%	46.69%
LONG-TERM LIABILITIES
Long-Term Debt	$192.2M	$188.7M	$188.7M
YoY Change	7.58%	7.57%	7.57%
Other Long-Term Liabilities	$1.545M	$1.645M	$4.357M
YoY Change	-15.16%	1.17%	-9.72%
Total Long-Term Liabilities	$193.7M	$190.4M	$193.1M
YoY Change	7.35%	11608.73%	7.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$48.02M	$57.15M	$57.15M
Total Long-Term Liabilities	$193.7M	$190.4M	$193.1M
Total Liabilities	$244.9M	$250.2M	$250.2M
YoY Change	8.68%	14.14%	14.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$376.3M	-$360.1M
YoY Change	28.19%	27.88%
Common Stock	$367.1M	$315.6M
YoY Change	63.24%	41.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$56.91M	$18.40M	$18.40M
YoY Change
Total Liabilities & Shareholders Equity	$301.8M	$268.6M	$268.6M
YoY Change	44.17%	27.28%	27.28%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$16.20M	-$20.54M	-$78.50M
YoY Change	35.67%	51.47%	4.38%
Depreciation, Depletion And Amortization	$900.0K	$1.222M	$2.800M
YoY Change	-3.85%	23.56%	-27.65%
Cash From Operating Activities	-$11.15M	-$8.148M	-$88.51M
YoY Change	-45.9%	-41.87%	69.68%
INVESTING ACTIVITIES
Capital Expenditures	$3.312M	$4.620M	$7.908M
YoY Change	666.67%	-55.7%	177.38%
Acquisitions			$0.00
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$6.626M	-$4.620M	-$24.55M
YoY Change	54.89%	-55.7%	-29.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$84.54M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$51.04M	65.00K	$86.23M
YoY Change	4214.71%	-99.74%	-13.99%
NET CHANGE
Cash From Operating Activities	-$11.15M	-8.148M	-$88.51M
Cash From Investing Activities	-$6.626M	-4.620M	-$24.55M
Cash From Financing Activities	$51.04M	65.00K	$86.23M
Net Change In Cash	$32.95M	-12.70M	-$26.32M
YoY Change	-240.14%	-2483.3%	-303.4%
FREE CASH FLOW
Cash From Operating Activities	-$11.15M	-$8.148M	-$88.51M
Capital Expenditures	$3.312M	$4.620M	$7.908M
Free Cash Flow	-$14.46M	-$12.77M	-$96.42M
YoY Change	-31.27%	-47.77%	75.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-19019000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-78583000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-72824000	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.72
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.72
CY2022	esta	Interest Costs Capitalized Construction In Progress InterestCostsCapitalizedConstructionInProgress	1762000	usd
CY2021	esta	Interest Costs Capitalized Construction In Progress InterestCostsCapitalizedConstructionInProgress	0	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	13278000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	161700000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	126682000	usd
CY2023	esta	Revenue From Contract With Customer Product Shelf Life RevenueFromContractWithCustomerProductShelfLife	P5Y
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	unit
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1155000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1024000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	561000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	329000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1079000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	233000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	773000	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	0	usd
CY2021Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Name AuditorName	Marcum LLP
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40035000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66355000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1841000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	741000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	46918000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35423000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	79471000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	36583000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8477000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11543000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	174901000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	149904000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	77205000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	51092000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	465000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	465000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7987000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4608000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3381000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3702000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4702000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1290000	usd
CY2023Q4	us-gaap	Assets Assets	268641000	usd
CY2022Q4	us-gaap	Assets Assets	211061000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	41624000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	20034000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13690000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17237000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1836000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1688000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	57150000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	38959000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	188739000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	175461000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2712000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3200000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1645000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1626000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	250246000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	219246000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26495250	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24815908	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26087180	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24407838	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	315634000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	223637000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	63748000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49911000	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	408070	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	408070	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2854000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2854000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-360096000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-281594000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1963000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2715000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18395000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8185000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	268641000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	211061000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	165151000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	161700000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	126682000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	58174000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	55105000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	41278000	usd
CY2023	us-gaap	Gross Profit GrossProfit	106977000	usd
CY2022	us-gaap	Gross Profit GrossProfit	106595000	usd
CY2021	us-gaap	Gross Profit GrossProfit	85404000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	145575000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	125984000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	92229000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26428000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20269000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18315000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	172003000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	146253000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	110544000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-65026000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-39658000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-25140000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	1020000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	87000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	23000	usd
CY2023	us-gaap	Interest Expense InterestExpense	15393000	usd
CY2022	us-gaap	Interest Expense InterestExpense	11760000	usd
CY2021	us-gaap	Interest Expense InterestExpense	9062000	usd
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	703000	usd
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	737000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	816000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3177000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6270000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39712000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-81000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2385000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1427000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-78502000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-75209000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-41139000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.08
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24457793	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23972722	shares
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-79254000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	74961000	usd
CY2021	esta	Share Based Payment Arrangement Shares Withheld For Cashless Option Exercise Value ShareBasedPaymentArrangementSharesWithheldForCashlessOptionExerciseValue	3000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	10407000	usd
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	356000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	784000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-41139000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	50739000	usd
CY2022	esta	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	0	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3873000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	13358000	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-942000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-75209000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8185000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	84538000	usd
CY2023	esta	Stock Issued During Period Value Issued After Initial Public Offering StockIssuedDuringPeriodValueIssuedAfterInitialPublicOffering	490000	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	255000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6673000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14362000	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	484000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-752000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-78502000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18395000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-78502000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-75209000	usd
CY2023	esta	Depreciationand Amortization Excluding Debt Discount Premium DepreciationandAmortizationExcludingDebtDiscountPremium	4166000	usd
CY2022	esta	Depreciationand Amortization Excluding Debt Discount Premium DepreciationandAmortizationExcludingDebtDiscountPremium	3870000	usd
CY2021	esta	Depreciationand Amortization Excluding Debt Discount Premium DepreciationandAmortizationExcludingDebtDiscountPremium	3718000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1223000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	111000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	200000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	1392000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	1577000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	338000	usd
CY2023	esta	Property Plant And Equipment Write Down PropertyPlantAndEquipmentWriteDown	-341000	usd
CY2022	esta	Property Plant And Equipment Write Down PropertyPlantAndEquipmentWriteDown	341000	usd
CY2021	esta	Property Plant And Equipment Write Down PropertyPlantAndEquipmentWriteDown	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3706000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	86000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	14362000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	13358000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	10407000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-280000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-229000	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-170000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	4181000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-1732000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-4200000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-19019000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	717000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	469000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	406000	usd
CY2023	esta	Gain Loss On Write Off Of Deferred Tax Liability Share Based Payment Arrangement GainLossOnWriteOffOfDeferredTaxLiabilityShareBasedPaymentArrangement	0	usd
CY2022	esta	Gain Loss On Write Off Of Deferred Tax Liability Share Based Payment Arrangement GainLossOnWriteOffOfDeferredTaxLiabilityShareBasedPaymentArrangement	1866000	usd
CY2021	esta	Gain Loss On Write Off Of Deferred Tax Liability Share Based Payment Arrangement GainLossOnWriteOffOfDeferredTaxLiabilityShareBasedPaymentArrangement	736000	usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	703000	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	737000	usd
CY2023	esta	Stock Compensation Issued In Lieu Of Cash Fees StockCompensationIssuedInLieuOfCashFees	495000	usd
CY2022	esta	Stock Compensation Issued In Lieu Of Cash Fees StockCompensationIssuedInLieuOfCashFees	0	usd
CY2021	esta	Stock Compensation Issued In Lieu Of Cash Fees StockCompensationIssuedInLieuOfCashFees	0	usd
CY2023	esta	Interest Costs Capitalized Construction In Progress InterestCostsCapitalizedConstructionInProgress	3567000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8124000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2074000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11557000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12333000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6695000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	42230000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10900000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7644000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2637000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4489000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1611000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-318000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	750000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-90000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	18957000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4376000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4959000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1662000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2815000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4726000	usd
CY2023	esta	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-689000	usd
CY2022	esta	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-378000	usd
CY2021	esta	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-408000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	97000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	117000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	143000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-88513000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-52166000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-27532000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7908000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2851000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2425000	usd
CY2023	esta	Paymentsto Acquire Assets Including Receivables Held PaymentstoAcquireAssetsIncludingReceivablesHeld	0	usd
CY2022	esta	Paymentsto Acquire Assets Including Receivables Held PaymentstoAcquireAssetsIncludingReceivablesHeld	525000	usd
CY2021	esta	Paymentsto Acquire Assets Including Receivables Held PaymentstoAcquireAssetsIncludingReceivablesHeld	434000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1328000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1491000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1447000	usd
CY2023	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	15311000	usd
CY2022	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	29924000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24547000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	usd
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	168093000	usd
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	71681000	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	26000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	175000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2173000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3873000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4583000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	484000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	356000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	86227000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	100255000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4052000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	513000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-358000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-465000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-26320000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	12940000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-31108000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66355000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53415000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84523000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40035000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66355000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53415000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	5689000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	5363000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	6927000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2165000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2125000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	652000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2847000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1129000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	22000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	2907000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	usd
CY2023	esta	Noncash Or Part Noncash Acquisition Noncash Equity Instrument Consideration NoncashOrPartNoncashAcquisitionNoncashEquityInstrumentConsideration	250000	usd
CY2022	esta	Noncash Or Part Noncash Acquisition Noncash Equity Instrument Consideration NoncashOrPartNoncashAcquisitionNoncashEquityInstrumentConsideration	0	usd
CY2021	esta	Noncash Or Part Noncash Acquisition Noncash Equity Instrument Consideration NoncashOrPartNoncashAcquisitionNoncashEquityInstrumentConsideration	0	usd
CY2023	esta	Noncash Consideration Payable Relatedto Asset Acquisition NoncashConsiderationPayableRelatedtoAssetAcquisition	0	usd
CY2022	esta	Noncash Consideration Payable Relatedto Asset Acquisition NoncashConsiderationPayableRelatedtoAssetAcquisition	0	usd
CY2021	esta	Noncash Consideration Payable Relatedto Asset Acquisition NoncashConsiderationPayableRelatedtoAssetAcquisition	546000	usd
CY2023	esta	Noncash Proceeds From Stock Options Exercised NoncashProceedsFromStockOptionsExercised	4500000	usd
CY2022	esta	Noncash Proceeds From Stock Options Exercised NoncashProceedsFromStockOptionsExercised	0	usd
CY2021	esta	Noncash Proceeds From Stock Options Exercised NoncashProceedsFromStockOptionsExercised	1640000	usd
CY2023Q4	esta	Number Of Manufacturing Facilities NumberOfManufacturingFacilities	2	facility
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements and accompanying notes. Significant accounting </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates and management judgments reflected in the consolidated financial statements </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">include items such as accounts receivable valuation and allowances, inventory valuation and allowances, valuation of acquired intangible assets, valuation of derivatives and valuation of deferred income tax assets, including tax valuation allowances. Estimates are based</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</span></div>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and accounts receivable. The majority of the Company’s cash is held at two financial institutions in the United States. Balances in the Company’s cash accounts exceed the Federal Deposit Insurance Corporation, or FDIC, limit of $250,000. The Company has not experienced any losses to its deposits of cash. </span></div><div style="margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s revenue has been derived from sales of its products in international markets, principally Europe, the Middle East, Latin America, and Asia. In the international markets in which the Company operates, the Company uses a combination of distributors and direct sales to customers. The Company performs ongoing credit evaluations of its distributors and customers, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s revenues were derived from the sale of Motiva Implants. During the years ended December 31, 2023, 2022 and 2021, no customer accounted for more than 10% of the Company’s revenue. Two customers accounted for 12.7% and 11.6% of the Company’s trade accounts receivable balance as of December 31, 2023, respectively. One customer accounted for 11.5% of the Company’s trade accounts receivable balance as of December 31, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on Avantor, Inc. (formerly NuSil Technology, LLC) as the sole supplier of medical-grade silicone used in Motiva Implants. During the years ended December 31, 2023, 2022 and 2021, the Company had purchases of $53.7 million, or 68.4% of total purchases, $32.1 million, or 38.2% of total purchases, and $23.1 million or 51.4% of total purchases, respectively, from Avantor Inc. As of December 31, 2023 and 2022, the Company had an outstanding balance owed to this vendor of $5.3 million and $5.6 million, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial condition and future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, unfavorable economic conditions, uncertainty of regulatory approval of the Company’s current and potential future products, uncertainty of market acceptance of the Company’s products, competition from substitute products and larger companies, securing and protecting proprietary technology, access to capital, strategic relationships and dependence on key individuals and sole source suppliers. </span></div>Products developed by the Company require clearances from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance that the products will receive the necessary clearances. If the Company is denied clearance, clearance is delayed, or the Company is unable to maintain its existing clearances, these developments could have a material adverse impact on the Company.
CY2023Q4	esta	Number Of Financial Institutions Holding Cash NumberOfFinancialInstitutionsHoldingCash	2	financial_institution
CY2023Q4	esta	Number Of Financial Institutions Holding Cash NumberOfFinancialInstitutionsHoldingCash	2	financial_institution
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2800000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	741000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1221000	usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1143000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1223000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	111000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	200000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	123000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	591000	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	122000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1841000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	741000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1221000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2649000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1167000	usd
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1625000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	1392000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	1577000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	338000	usd
CY2023	esta	Inventory Write Off InventoryWriteOff	111000	usd
CY2022	esta	Inventory Write Off InventoryWriteOff	95000	usd
CY2021	esta	Inventory Write Off InventoryWriteOff	796000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1167000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	165151000	usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt and Embedded Derivatives</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the accounting standards for derivatives and for distinguishing liabilities from equity when accounting for hybrid contracts. The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (see Note 5).</span></div>
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1800000	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior year amounts to conform to the current year presentation. These reclassifications had no material impact on the Company’s financial position as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2023</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or results of operations for year ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2023</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div>
CY2023Q4	esta	Prepaid Construction In Progress Current PrepaidConstructionInProgressCurrent	13000	usd
CY2022Q4	esta	Prepaid Construction In Progress Current PrepaidConstructionInProgressCurrent	2240000	usd
CY2023Q4	esta	Prepaid Services Current PrepaidServicesCurrent	420000	usd
CY2022Q4	esta	Prepaid Services Current PrepaidServicesCurrent	685000	usd
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	1073000	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	1400000	usd
CY2023Q4	esta	Prepaid Assets Current PrepaidAssetsCurrent	394000	usd
CY2022Q4	esta	Prepaid Assets Current PrepaidAssetsCurrent	991000	usd
CY2023Q4	us-gaap	Supplies Supplies	468000	usd
CY2022Q4	us-gaap	Supplies Supplies	433000	usd
CY2023Q4	esta	Prepaid Clinical Trial Costs Current PrepaidClinicalTrialCostsCurrent	176000	usd
CY2022Q4	esta	Prepaid Clinical Trial Costs Current PrepaidClinicalTrialCostsCurrent	300000	usd
CY2023Q4	esta	Prepaid Warranty And Distribution Rights Current PrepaidWarrantyAndDistributionRightsCurrent	275000	usd
CY2022Q4	esta	Prepaid Warranty And Distribution Rights Current PrepaidWarrantyAndDistributionRightsCurrent	238000	usd
CY2023Q4	esta	Prepaid Software PrepaidSoftware	506000	usd
CY2022Q4	esta	Prepaid Software PrepaidSoftware	1090000	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2405000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1568000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8477000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11543000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	93532000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	64713000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16327000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13621000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	51092000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	912000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	833000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	724000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	506000	usd
CY2023Q4	esta	Accrued Stock Option Grant Bonus Current AccruedStockOptionGrantBonusCurrent	0	usd
CY2022Q4	esta	Accrued Stock Option Grant Bonus Current AccruedStockOptionGrantBonusCurrent	4500000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	773000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	773000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	688000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	688000	usd
CY2023Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	344000	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	712000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1269000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1203000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	119000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	171000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	109000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	130000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1402000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	491000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13690000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17237000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1836000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1688000	usd
CY2023Q4	esta	Other Sundry Liabilities Noncurrent Net OtherSundryLiabilitiesNoncurrentNet	147000	usd
CY2022Q4	esta	Other Sundry Liabilities Noncurrent Net OtherSundryLiabilitiesNoncurrentNet	-44000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	465000	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q4	us-gaap	Goodwill Goodwill	465000	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	14451000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6464000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7987000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	9894000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5286000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4608000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	185000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	427000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3681000	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023Q4	esta	Number Of Tranches NumberOfTranches	4	tranche
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	295000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-7000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	104000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2023	us-gaap	Lease Cost LeaseCost	846000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3381000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	688000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3200000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	998000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	321000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	332000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	343000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	355000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	368000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	315000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	2034000	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26495250	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24815908	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26087180	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24407838	shares
CY2023Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	84600000	usd
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	5672448	shares
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	5157807	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14362000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13358000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10407000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1873165	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	42.73
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y21D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	47273000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	41.17
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	139916	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	64.77
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	349967	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	19.06
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	175727	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	67.35
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1487387	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	47.47
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M7D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4308000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	931798	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	39.57
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	4000000	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	349967	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	19.06
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5100000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	15000000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	28700000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	12700000	usd
CY2023	esta	Employee And Non Employee Service Sharebased Compensation Nonvested Awards Compensation Cost Notyet Recognized Periodfor Recognition EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition	P1Y10M24D
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.300
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	18070000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.229
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	15978000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.220
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	9430000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.240
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-13556000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-9721000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	4027000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-65027000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-63103000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-43739000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-78583000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-72824000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39712000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	297000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	114000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	289000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3328000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2185000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1131000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3625000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2299000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1420000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-3706000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	86000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	7000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3706000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	86000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-81000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2385000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1427000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-23575000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.300
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-21847000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.300
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-11914000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	2000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2023	esta	Effective Income Tax Rate Reconciliation Returnto Provision Adjustment Amount EffectiveIncomeTaxRateReconciliationReturntoProvisionAdjustmentAmount	-539000	usd
CY2023	esta	Effective Income Tax Rate Reconciliation Returnto Provision Adjustment Percent EffectiveIncomeTaxRateReconciliationReturntoProvisionAdjustmentPercent	0.007
CY2022	esta	Effective Income Tax Rate Reconciliation Returnto Provision Adjustment Amount EffectiveIncomeTaxRateReconciliationReturntoProvisionAdjustmentAmount	2651000	usd
CY2022	esta	Effective Income Tax Rate Reconciliation Returnto Provision Adjustment Percent EffectiveIncomeTaxRateReconciliationReturntoProvisionAdjustmentPercent	-0.040
CY2021	esta	Effective Income Tax Rate Reconciliation Returnto Provision Adjustment Amount EffectiveIncomeTaxRateReconciliationReturntoProvisionAdjustmentAmount	384000	usd
CY2021	esta	Effective Income Tax Rate Reconciliation Returnto Provision Adjustment Percent EffectiveIncomeTaxRateReconciliationReturntoProvisionAdjustmentPercent	-0.010
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	52000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	53000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.002
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	438000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.006
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3573000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.050
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	7043000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.180
CY2023	esta	Effective Income Tax Rate Reconciliation Tax Holiday Adjustment Expense Benefit EffectiveIncomeTaxRateReconciliationTaxHolidayAdjustmentExpenseBenefit	-4386000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Holidays EffectiveIncomeTaxRateReconciliationTaxHolidays	0.056
CY2022	esta	Effective Income Tax Rate Reconciliation Tax Holiday Adjustment Expense Benefit EffectiveIncomeTaxRateReconciliationTaxHolidayAdjustmentExpenseBenefit	-3030000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Holidays EffectiveIncomeTaxRateReconciliationTaxHolidays	0.040
CY2021	esta	Effective Income Tax Rate Reconciliation Tax Holiday Adjustment Expense Benefit EffectiveIncomeTaxRateReconciliationTaxHolidayAdjustmentExpenseBenefit	918000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Holidays EffectiveIncomeTaxRateReconciliationTaxHolidays	-0.020
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	984000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.013
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1353000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.020
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-2681000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.070
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	162000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.002
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	301000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	134000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.004
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-81000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.001
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2385000	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.030
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1427000	usd
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.042
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	567000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	348000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	4000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1198000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	125000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	143000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	661000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1404000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	25087000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	19933000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	336000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	232000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	293000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	144000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23380000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	22942000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	3693000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	172000	usd
CY2023Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	500000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.30
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	100000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-78502000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-75209000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-41139000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25600029	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25600029	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24457793	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24457793	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23972722	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23972722	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.07
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.07
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.08
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.08
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.72
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.72
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1683564	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1787808	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1857569	shares

Files In Submission

Name	View Source	Status
0001688757-24-000034-index-headers.html	Edgar Link	pending
0001688757-24-000034-index.html	Edgar Link	pending
0001688757-24-000034.txt	Edgar Link	pending
0001688757-24-000034-xbrl.zip	Edgar Link	pending
esta-20231231.htm	Edgar Link	pending
esta-20231231.xsd	Edgar Link	pending
esta-20231231_g1.jpg	Edgar Link	pending
esta-20231231_g10.jpg	Edgar Link	pending
esta-20231231_g11.jpg	Edgar Link	pending
esta-20231231_g12.jpg	Edgar Link	pending
esta-20231231_g13.jpg	Edgar Link	pending
esta-20231231_g14.jpg	Edgar Link	pending
esta-20231231_g2.jpg	Edgar Link	pending
esta-20231231_g3.jpg	Edgar Link	pending
esta-20231231_g4.jpg	Edgar Link	pending
esta-20231231_g5.jpg	Edgar Link	pending
esta-20231231_g6.jpg	Edgar Link	pending
esta-20231231_g7.jpg	Edgar Link	pending
esta-20231231_g8.jpg	Edgar Link	pending
esta-20231231_g9.jpg	Edgar Link	pending
esta10k-exhibit1011q42023.htm	Edgar Link	pending
esta10k-exhibit211q4_2023.htm	Edgar Link	pending
esta10k-exhibit231q4_2023.htm	Edgar Link	pending
esta10k-exhibit311q4_2023.htm	Edgar Link	pending
esta10k-exhibit312q4_2023.htm	Edgar Link	pending
esta10k-exhibit321q4_2023.htm	Edgar Link	pending
esta10k-exhibit971q4_2023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_1.jpg	Edgar Link	pending
image_10.jpg	Edgar Link	pending
image_100.jpg	Edgar Link	pending
image_101.jpg	Edgar Link	pending
image_102.jpg	Edgar Link	pending
image_103.jpg	Edgar Link	pending
image_104.jpg	Edgar Link	pending
image_105.jpg	Edgar Link	pending
image_106.jpg	Edgar Link	pending
image_107.jpg	Edgar Link	pending
image_108.jpg	Edgar Link	pending
image_109.jpg	Edgar Link	pending
image_11.jpg	Edgar Link	pending
image_110.jpg	Edgar Link	pending
image_111.jpg	Edgar Link	pending
image_112.jpg	Edgar Link	pending
image_113.jpg	Edgar Link	pending
image_114.jpg	Edgar Link	pending
image_115.jpg	Edgar Link	pending
image_116.jpg	Edgar Link	pending
image_117.jpg	Edgar Link	pending
image_118.jpg	Edgar Link	pending
image_119.jpg	Edgar Link	pending
image_12.jpg	Edgar Link	pending
image_120.jpg	Edgar Link	pending
image_121.jpg	Edgar Link	pending
image_122.jpg	Edgar Link	pending
image_123.jpg	Edgar Link	pending
image_124.jpg	Edgar Link	pending
image_125.jpg	Edgar Link	pending
image_126.jpg	Edgar Link	pending
image_127.jpg	Edgar Link	pending
image_128.jpg	Edgar Link	pending
image_129.jpg	Edgar Link	pending
esta-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
esta-20231231_htm.xml	Edgar Link	completed
image_13.jpg	Edgar Link	pending
image_130.jpg	Edgar Link	pending
image_131.jpg	Edgar Link	pending
image_132.jpg	Edgar Link	pending
image_133.jpg	Edgar Link	pending
image_134.jpg	Edgar Link	pending
image_135.jpg	Edgar Link	pending
image_136.jpg	Edgar Link	pending
image_137.jpg	Edgar Link	pending
image_138.jpg	Edgar Link	pending
image_139.jpg	Edgar Link	pending
image_14.jpg	Edgar Link	pending
image_140.jpg	Edgar Link	pending
image_141.jpg	Edgar Link	pending
image_142.jpg	Edgar Link	pending
image_143.jpg	Edgar Link	pending
image_144.jpg	Edgar Link	pending
image_145.jpg	Edgar Link	pending
image_146.jpg	Edgar Link	pending
image_147.jpg	Edgar Link	pending
image_148.jpg	Edgar Link	pending
image_149.jpg	Edgar Link	pending
image_15.jpg	Edgar Link	pending
image_150.jpg	Edgar Link	pending
image_151.jpg	Edgar Link	pending
image_152.jpg	Edgar Link	pending
image_153.jpg	Edgar Link	pending
image_154.jpg	Edgar Link	pending
image_155.jpg	Edgar Link	pending
image_156.jpg	Edgar Link	pending
image_157.jpg	Edgar Link	pending
image_158.jpg	Edgar Link	pending
image_159.jpg	Edgar Link	pending
image_16.jpg	Edgar Link	pending
image_160.jpg	Edgar Link	pending
image_161.jpg	Edgar Link	pending
image_162.jpg	Edgar Link	pending
image_163.jpg	Edgar Link	pending
image_164.jpg	Edgar Link	pending
image_165.jpg	Edgar Link	pending
image_166.jpg	Edgar Link	pending
image_167.jpg	Edgar Link	pending
image_168.jpg	Edgar Link	pending
image_169.jpg	Edgar Link	pending
image_17.jpg	Edgar Link	pending
image_170.jpg	Edgar Link	pending
image_171.jpg	Edgar Link	pending
image_172.jpg	Edgar Link	pending
image_173.jpg	Edgar Link	pending
image_174.jpg	Edgar Link	pending
image_18.jpg	Edgar Link	pending
image_19.jpg	Edgar Link	pending
image_2.jpg	Edgar Link	pending
image_20.jpg	Edgar Link	pending
image_21.jpg	Edgar Link	pending
image_22.jpg	Edgar Link	pending
image_23.jpg	Edgar Link	pending
image_24.jpg	Edgar Link	pending
image_25.jpg	Edgar Link	pending
image_26.jpg	Edgar Link	pending
image_27.jpg	Edgar Link	pending
image_28.jpg	Edgar Link	pending
image_29.jpg	Edgar Link	pending
image_3.jpg	Edgar Link	pending
image_30.jpg	Edgar Link	pending
image_31.jpg	Edgar Link	pending
image_32.jpg	Edgar Link	pending
image_33.jpg	Edgar Link	pending
image_34.jpg	Edgar Link	pending
image_35.jpg	Edgar Link	pending
image_36.jpg	Edgar Link	pending
image_37.jpg	Edgar Link	pending
image_38.jpg	Edgar Link	pending
image_39.jpg	Edgar Link	pending
image_4.jpg	Edgar Link	pending
image_40.jpg	Edgar Link	pending
image_41.jpg	Edgar Link	pending
image_42.jpg	Edgar Link	pending
image_43.jpg	Edgar Link	pending
image_44.jpg	Edgar Link	pending
image_45.jpg	Edgar Link	pending
image_46.jpg	Edgar Link	pending
image_47.jpg	Edgar Link	pending
image_48.jpg	Edgar Link	pending
image_49.jpg	Edgar Link	pending
image_5.jpg	Edgar Link	pending
image_50.jpg	Edgar Link	pending
image_51.jpg	Edgar Link	pending
image_52.jpg	Edgar Link	pending
image_53.jpg	Edgar Link	pending
image_54.jpg	Edgar Link	pending
image_55.jpg	Edgar Link	pending
image_56.jpg	Edgar Link	pending
image_57.jpg	Edgar Link	pending
image_58.jpg	Edgar Link	pending
image_59.jpg	Edgar Link	pending
image_6.jpg	Edgar Link	pending
image_60.jpg	Edgar Link	pending
image_61.jpg	Edgar Link	pending
image_62.jpg	Edgar Link	pending
image_63.jpg	Edgar Link	pending
image_64.jpg	Edgar Link	pending
image_65.jpg	Edgar Link	pending
image_66.jpg	Edgar Link	pending
image_67.jpg	Edgar Link	pending
image_68.jpg	Edgar Link	pending
image_69.jpg	Edgar Link	pending
image_7.jpg	Edgar Link	pending
image_70.jpg	Edgar Link	pending
image_71.jpg	Edgar Link	pending
image_72.jpg	Edgar Link	pending
image_73.jpg	Edgar Link	pending
image_74.jpg	Edgar Link	pending
image_75.jpg	Edgar Link	pending
image_76.jpg	Edgar Link	pending
image_77.jpg	Edgar Link	pending
image_78.jpg	Edgar Link	pending
image_79.jpg	Edgar Link	pending
image_8.jpg	Edgar Link	pending
image_80.jpg	Edgar Link	pending
image_81.jpg	Edgar Link	pending
image_82.jpg	Edgar Link	pending
image_83.jpg	Edgar Link	pending
image_84.jpg	Edgar Link	pending
image_85.jpg	Edgar Link	pending
image_86.jpg	Edgar Link	pending
image_87.jpg	Edgar Link	pending
image_88.jpg	Edgar Link	pending
image_89.jpg	Edgar Link	pending
image_9.jpg	Edgar Link	pending
image_90.jpg	Edgar Link	pending
image_91.jpg	Edgar Link	pending
image_92.jpg	Edgar Link	pending
image_93.jpg	Edgar Link	pending
image_94.jpg	Edgar Link	pending
image_95.jpg	Edgar Link	pending
image_96.jpg	Edgar Link	pending
image_97.jpg	Edgar Link	pending
image_98.jpg	Edgar Link	pending
image_99.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
esta-20231231_lab.xml	Edgar Link	unprocessable
esta-20231231_cal.xml	Edgar Link	unprocessable
esta-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2024 Q1 Form 10-K Financial Statement

#000168875724000034 Filed on March 04, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2024 Q1 Form 10-K Financial Statement

#000168875724000034 Filed on March 04, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta